Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation

Molecular and Cellular Biology

Volumn 26, Issue 2, 2006, Pages 654-667

  Ju, Wenjun ^a   Ogawa, Atsushi ^b   Heyer, Joerg ^c   Nierhof, Dirk ^b   Yu, Liping ^a   Kucherlapati, Raju ^c   Shafritz, David A ^b   Böttinger, Erwin P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; CRE RECOMBINASE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENT; GENE DELETION; GENE TARGETING; GROWTH INHIBITION; LIVER CELL; LIVER REGENERATION; LIVER TRANSPLANTATION; LOXP SITE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE POISONING; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; HEPATITIS, TOXIC; HEPATOCYTES; LIVER; MESODERM; MICE; MICE, KNOCKOUT; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MAMMALIA;

EID: 30644479959     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.2.654-667.2006     Document Type: Article

References (53)

1. Böttinger, E. P., and M. Bitzer. 2002. TGF-ss signaling in renal disease. J. Am. Soc. Nephrol. 13:2600-2610.
2. Böttinger, E. P., V. M. Factor, M. L. Tsang, J. A. Weatherbee, J. B. Kopp, S. W. Qian, L. M. Wakefleld, A. B. Roberts, S. S. Thorgeirsson, and M. B. Sporn. 1996. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc. Natl. Acad. Sci. USA 93:5877-5882.
3. Braun, L., J. E. Mead, M. Panzica, R. Mikumo, G. I. Bell, and N. Fausto. 1988. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 85:1539-1543.
4. Cano, A., M. A. Perez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. del Barrio, F. Portillo, and M. A. Nieto. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76-83.
5. Carr, B. I., I. Hayashi, E. L. Branum, and H. L. Moses. 1986. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res. 46:2330-2334.
6. Conery, A. R., Y. Cao, E. A. Thompson, C. M. Townsend, Jr., T. C. Ko, and K. Luo. 2004. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis. Nat. Cell Biol. 6:366-372.
7. Datto, M. B., J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X. F. Wang. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19:2495-2504.
8. Dennler, S., S. Huet, and J. M. Gauthier. 1999. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18:1643-1648.
9. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577-584.
10. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression, Nat. Genet. 29:117-129.
11. Dunn, N. R., S. D. Vincent, L. Oxburgh, E. J. Robertson, and E. K. Bikoff. 2004. Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo. Development 131:1717-1728.
12. Dunn, N. R., C. H. Koonce, D. C. Anderson, A. Islam, E. K. Bikoff, and E. J. Robertson. 2005. Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev. 19:152-163.
13. Flanders, K. C. 2004. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85:47-64.
14. Furuta, K., S. Misao, K. Takahashi, T. Tagaya, Y. Fukuzawa, T. Ishikawa, K. Yoshioka, and S. Kakumu. 1999. Gene mutation of transforming growth factor betal type II receptor in hepatocellular carcinoma. Int. J. Cancer 81:851-853.
15. Hay, E. D. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat. 154:8-20.
16. Heyer, J., D. Escalante-Alcalde, M. Lia, E. Boettinger, W. Edelmann, C. L. Stewart, and R. Kucherlapati. 1999. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci, USA 96:12595-12600,
17. Ioffe, E., Y. Liu, M. Bhaumik, F. Poirier, S. M. Factor, and P. Stanley. 1995. WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc. Natl. Acad. Sci. USA 92:7357-7361.
18. Kawate, S., S. Takenoshita, S. Ohwada, A. Mogi, T. Fukusato, F. Makita, H. Kuwano, and Y. Morishita. 1999. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma. Int. J. Oncol. 14:127-131.
19. Li, A. G., S. L. Lu, M. X. Zhang, C. Deng, and X. J. Wang. 2004. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res. 64:7836-7845.
20. Liu, Y., M. H. Testing, M. Hester, J. C. Thompson, and M. Weinstein. 2004. Generation of novel conditional and hypomorphic alleles of the Smad2 gene. Genesis 40:118-123.
21. Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:2196-2206.
22. Macias-Silva, M., W. Li, J. I. Leu, M. A. Crissey, and R. Taub. 2002. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J. Biol. Chem. 277:28483-28490.
23. Massague, J. 2000. How cells read TGF-β signals. Nat. Rev. Mol. Cell. Biol. 1:169-178.
24. Michalopoulos, G. K., and M. C. DeFrances. 1997. Liver regeneration. Science 276:60-66.
25. Miyazono, K., P. ten Dijke, and C. H. Heldin. 2000. TGF-β signaling by Smad proteins. Adv. Immunol. 75:115-157.
26. Motokura, T., and A. Arnold. 1993. Cyclin D and oncogenesis. Curr. Opin. Genet. Dev. 3:5-10.
27. Neufeld, D. S. 1997. Isolation of rat liver hepatocytes. Methods Mol. Biol. 75:145-151.
28. Nomura, M., and E. Li. 1998. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393:786-790.
29. Oberhammer, F., G. Fritsch, M. Pavelka, G. Froschl, R. Tiefenbacher, T. Purchio, and R. Schulte-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease. Toxicol. Lett. 64-65(Spec. No.):701-704.
30. Oe, S., E. R. Lemmer, E. A. Conner, V. M. Factor, P. Leveen, J. Larsson, S. Karlsson, and S. S. Thorgeirsson. 2004. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 40:1098-1105.
31. Postic, C., M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knockouts using Cre recombinase. J. Biol. Chem. 274:305-315.
32. Postic, C., and M. A. Magnuson. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26:149-150.
33. Randall, R. A., M. Howell, C. S. Page, A. Daly, P. A. Bates, and C. S. Hill. 2004. Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif. Mol. Cell. Biol. 24:1106-1121.
34. Remy, I., A. Montmarquette, and S. W. Michnick. 2004. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat. Cell Biol. 6:358-365.
35. Roberts, A. B., and L. M. Wakefleld. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100:8621-8623.
36. Romero-Gallo, J., E. G. Sozmen, A. Chytil, W. E. Russell, R. Whitehead, W. T. Parks, M. S. Holdren, M. F. Her, S. Gautam, M. Magnuson, H. L. Moses, and W. M. Grady. 2005. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene.
37. Sato, M., Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima. 2003. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Investig. 112:1486-1494.
38. Schiffer, M., M. Bitzer, I. S. Roberts, J. B. Kopp, P. ten Dijke, P. Mundel, and E. P. Bottinger. 2001. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Investig. 108:807-816.
39. Sjoblom, T., I. Yakymovych, C. H. Heldin, A. Ostman, and S. Souchelnytskyi. 2004. Smad2 suppresses the growth of Mv1Lu cells subcutaneously inoculated in mice. Eur. J. Cancer 40:267-274.
40. ten Dijke, P., M. J. Goumans, F. Itoh, and S. Itoh. 2002. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191:1-16.
41. Valcourt, U., M. Kowanetz, H. Niimi, C. H. Heldin, and A. Moustakas. 2005. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell.
42. Valdes, F., A. M. Alvarez, A. Locascio, S. Vega, B. Herrera, M. Fernandez, M. Benito, M. A. Nieto, and I. Fabregat. 2002. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol. Cancer Res. 1:68-78.
43. Vijayachandra, K., J. Lee, and A. B. Glick. 2003. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 63:3447-3452.
44. Vincent, S. D., N. R. Dunn, S. Hayashi, D. P. Norris, and E. J. Robertson. 2003. Cell fate decisions within the mouse organizer are governed by graded nodal signals. Genes Dev. 17:1646-1662.
45. Waldrip, W. R., E. K. Bikoff, P. A. Hoodless, J. L. Wrana, and E. J. Robertson. 1998. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808.
46. Weinstein, M., X. Yang, C. Li, X. Xu, J. Gotay, and C. X. Deng. 1998. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. USA 95:9378-9383.
47. Yagi, K., D. Goto, T. Hamamoto, S. Takenoshita, M. Kato, and K. Miyazono. 1999. Alternatively spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274:703-709.
48. Yakicier, M. C., M. B. Irmak, A. Romano, M. Kew, and M. Ozturk. 1999. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18:4879-4883.
49. Yang, Y. C., E. Pick, J. Zavadil, D. Liang, D. Xie, J. Heyer, P. Pavlidis, R. Kucherlapati, A. B. Roberts, and E. P. Bottinger. 2003. Hierarchical model of gene regulation by transforming growth factor beta. Proc. Natl. Acad. Sci. USA 100:10269-10274.
50. Yang, X., J. J. Letterio, R. J. Uchleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-β. EMBO J. 18:1280-1291.
51. Yang, Y. A., B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C. X. Deng, and L. M. Wakefleld. 2002. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ. 13:123-130.
52. Kip1 inactivation provides a proliferative advantage to transplanted hepatocytes in DPPIV/Rag2 double knockout mice after repeated host liver injury. Cell Transplant. 12:907-919.
53. Zavadil, J., L. Cermak, N. Soto-Nieves, and E. P. Bottinger. 2004. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23:1155-1165.